Drug Approval | February 10, 2025
NATCO, Lupin receive ANDA approval for Bosentan tablets for oral suspension
TFOS is indicated for the treatment of pulmonary arterial hypertension
TFOS is indicated for the treatment of pulmonary arterial hypertension
The company will showcase groundbreaking innovations from its Pharma and Nutrition divisions, highlighting key ingredients and formulations designed to support holistic well-being
The inspection was carried out from January 28 to February 1, 2025
Everolimus TFOS is a kinase inhibitor indicated in adult and paediatric patients aged one year and older with tuberous sclerosis complex for the treatment of subependymal giant cell astrocytoma
SIM0500 is a humanized trispecific antibody that targets GPRC5D, BCMA, and CD3
The site’s GMP Certification has been successfully renewed
Cenexi is committed to working closely with the ANSM to address the observations
Infections with H. pylori affect over 43 percent of the world’s population with a wide range of gastrointestinal disorders
The company will receive GMP compliance certificate which will further help to accelerate the business growth across the globe
Brenntag Specialties Pharma marks a strategic milestone with its first collaboration with a contract manufacturer to enhance its nutraceutical value chain
Subscribe To Our Newsletter & Stay Updated
